SCHEMBL728435

SCHEMBL728435

CCCCCCC(=O)N(CC)CCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA9 Q16790 2/20 0.53
KDM5A P29375 2/20 0.49
PHF8 Q9UPP1 2/20 0.49
KDM4C Q9H3R0 1/20 0.49
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP3 P08254 1/20 0.48
MMP8 P22894 1/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
GPR84 Q9NQS5 6/20 0.46
PPARG P37231 6/20 0.46
PPARD Q03181 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9419542 1.00 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL9657056 1.00 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL17501644 1.00 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL20863008 0.98 LMNA (0.60) LMNACA12CA1CA9KDM5A
SCHEMBL28581774 0.96 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL28723570 0.96 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL28328035 0.96 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL27699391 0.96 LMNA (0.58) LMNACA12CA1CA9KDM5A
SCHEMBL12640149 0.96 LMNA (0.58) LMNACA12CA1CA9CES2
SCHEMBL28595401 0.94 LMNA (0.60) LMNACA12CA1CA9KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484847-B1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OXFA GMBH (DE) 2020-10-28 EP claimed
EP-3484846-B1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OXFA GMBH (DE) 2020-09-23 EP claimed
US-10689320-B2 Method for separating formic acid from a reaction mixture by means of extraction OXFA GMBH (DE) 2020-06-23 US claimed
US-20190291093-A1 Method for Catalytically Producing Formic Acid and Regenerating the Catalyst Used in the Process with Little Overpressure OXFA GMBH (DE) 2019-09-26 US claimed
US-20190248727-A1 Method for Separating Formic Acid from a Reaction Mixture by Means of Extraction OXFA GMBH (DE) 2019-08-15 US claimed
EP-3484846-A1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OxFA GmbH (DE) 2019-05-22 EP claimed
EP-3484847-A1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OxFA GmbH (DE) 2019-05-22 EP claimed
WO-2018015351-A1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OXFA GMBH (DE) 2018-01-25 WO claimed
WO-2018015352-A1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OXFA GMBH (DE) 2018-01-25 WO claimed
US-8759575-B2 Method for catalytically producing formic acid JBACH GMBH (DE) 2014-06-24 US claimed
US-20030036664-A1 Waste water treatment in a method for producing formic acid which is free of water BASF AKTIENGESELLSCHAFT (DE) 2003-02-20 US claimed
US-20030009057-A1 Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid BASF AKTIENGESELLSCHAFT (DE) 2003-01-09 US claimed
EP-1254099-A2 PROCESS FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-11-06 EP claimed
EP-1250305-A2 WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
EP-1250307-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
EP-1250306-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
WO-2001055069-A2 WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055071-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055070-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055077-A2 FACILITY AND METHOD FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009057-A1 Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid F2, ACSL3, ACSL1 LMNA 2505/4885CA12 1372/4885CA1 300/4885
US-20030036664-A1 Waste water treatment in a method for producing formic acid which is free of water MGAM, ESD, SMOX LMNA 2882/4885CA12 279/4885CA1 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.